Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2022 5
2023 5
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean dassinger (91 results)?
Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: insights from the multicentric FACE-SZ dataset.
Misdrahi D, Dupuy M, Dansou Y, Boyer L, Berna F, Capdevielle D, Chereau I, Coulon N, D'Amato T, Dubertret C, Leignier S, Llorca PM, Lançon C, Mallet J, Passerieux C, Pignon B, Rey R, Schürhoff F, Swendsen J, Urbach M, Szöke A, Godin O, Fond G; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group. Misdrahi D, et al. Transl Psychiatry. 2023 Nov 7;13(1):341. doi: 10.1038/s41398-023-02640-x. Transl Psychiatry. 2023. PMID: 37935695 Free PMC article.
3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohort.
Godin O, Pignon B, Szoke A, Boyer L, Aouizerate B, Schorr B, André M, Capdevielle D, Chereau I, Coulon N, Dassing R, Dubertret C, Etain B, Leignier S, Llorca PM, Mallet J, Misdrahi D, Passerieux C, Rey R, Urbach M, Schürhoff F, Leboyer M, Fond G. Godin O, et al. Among authors: dassing r. Prog Neuropsychopharmacol Biol Psychiatry. 2023 Jan 10;120:110641. doi: 10.1016/j.pnpbp.2022.110641. Epub 2022 Sep 17. Prog Neuropsychopharmacol Biol Psychiatry. 2023. PMID: 36122839
Clinical and pharmacological correlates of caffeine consumption in subjects with schizophrenia - Data from the FACE-SZ cohort.
Szoke A, Richard JR, Fond G, Misdrahi D, Lajnef M, Aouizerate B, Boyer L, Berna F, Capdevielle D, André M, Chereau I, Clauss-Kobayashi J, Coulon N, Dubertret C, Leignier S, Llorca PM, Mallet J, Passerieux C, Rey R, Schorr B, Urbach M, Leboyer M, Pignon B, Schürhoff F; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Szoke A, et al. J Psychiatr Res. 2023 May;161:206-212. doi: 10.1016/j.jpsychires.2023.03.017. Epub 2023 Mar 13. J Psychiatr Res. 2023. PMID: 36934602
Clinical and cognitive characteristics of subjects with schizophrenia and childhood attention-deficit/hyperactivity disorder: Results from the multicentric FACE-SZ cross-sectional dataset.
Dondé C, Coulon N, Turbé H, Andre M, Boyer L, Capdevielle D, Chereau I, Dassing R, Dorey JM, Dubertret C, Leignier S, Llorca PM, Misdrahi D, Passerieux C, Pignon B, Rey R, Schorr B, Schürhoff F, Urbach M, Fond G, Mallet J. Dondé C, et al. Among authors: dassing r. Schizophr Res. 2024 Feb;264:105-112. doi: 10.1016/j.schres.2023.12.010. Epub 2023 Dec 20. Schizophr Res. 2024. PMID: 38128341
Recommendations of the Schizophrenia Expert Center network for adequate physical activity in real-world schizophrenia (FACE-SZ).
Sunhary De Verville PL, Stubbs B, Etchecopar-Etchart D, Godin O, Andrieu-Haller C, Berna F, Aouizerate B, Capdevielle D, Chereau I, Clauss-Kobayashi J, Coulon N, Dorey JM, Dubertret C, Leignier S, Mallet J, Misdrahi D, Passerieux C, Pignon B, Rey R, Urbach M, Llorca PM, Schürhoff F, Lançon C, Boyer L, Fond G; Collaborators: the FACE-S. Z. (FondaMental Academic Centers of Expertise for Schizophrenia) Group. Sunhary De Verville PL, et al. Eur Arch Psychiatry Clin Neurosci. 2022 Oct;272(7):1273-1282. doi: 10.1007/s00406-022-01384-x. Epub 2022 Apr 20. Eur Arch Psychiatry Clin Neurosci. 2022. PMID: 35441901
The impact of parent history of severe mental illness on schizophrenia outcomes: results from the real-world FACE-SZ cohort.
Garosi A, Sunhary de Verville PL, Etchecopar-Etchart D, Richieri R, Godin O, Schürhoff F, Berna F, Aouizerate B, Capdevielle D, Chereau I, Clauss-Kobayashi J, Dorey JM, Dubertret C, Coulon N, Leignier S, Mallet J, Misdrahi D, Passerieux C, Rey R, Szoke A, Urbach M, Leboyer M, Llorca PM, Lançon C, Boyer L, Fond G; Collaborators : the FACE-SZ (Fonda Mental Academic Centers of Expertise for Schizophrenia) group. Garosi A, et al. Eur Arch Psychiatry Clin Neurosci. 2023 Jun;273(4):825-837. doi: 10.1007/s00406-022-01449-x. Epub 2022 Jul 19. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 35852617
Subtyping chronic catatonia: Clinical and neuropsychological characteristics of progressive periodic catatonia and chronic system catatonias vs. non-catatonic schizophrenia.
Schorr B, Clauss JME, de Billy CC, Dassing R, Zinetti-Bertschy A, Domergny-Jeanjean LC, Obrecht A, Mainberger O, Schürhoff F, Foucher JR, Berna F. Schorr B, et al. Among authors: dassing r. Schizophr Res. 2024 Jan;263:55-65. doi: 10.1016/j.schres.2022.10.009. Epub 2022 Nov 18. Schizophr Res. 2024. PMID: 36411196
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort.
Vidal N, Roux P, Urbach M, Belmonte C, Boyer L, Capdevielle D, Clauss-Kobayashi J, D'Amato T, Dassing R, Dubertret C, Dubreucq J, Fond G, Honciuc RM, Leignier S, Llorca PM, Mallet J, Misdrahi D, Pignon B, Rey R, Schürhoff F, Tessier A; FACE-SZ (FondaMental Academic Centers of Expertise—Schizophrenia) Group; Passerieux C, Brunet-Gouet E. Vidal N, et al. Among authors: dassing r. Front Pharmacol. 2024 Jun 12;15:1403093. doi: 10.3389/fphar.2024.1403093. eCollection 2024. Front Pharmacol. 2024. PMID: 38933674 Free PMC article.